secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bausch Health Companies Inc. (BHC)
CIK:        0000885590
Form:       8-K
Filed at:   2025-09-11T23:59:59+00:00
Accession:  0001193125-25-200869
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bausch Health completes acquisition of DURECT for $1.75/share plus CVRs
-----------------------------------------------------------------------

- Tender offer closed with 62% of DURECT shares (19.98M) validly tendered and accepted.
- Price: $1.75 per share in cash plus one contingent value right per share.
- CVRs provide up to $350M aggregate milestone payments (net of retention bonuses).
- BHC Lyon merged into DURECT; DURECT now a wholly-owned subsidiary of Bausch Health Americas.
- Transaction consummated on September 11, 2025 after all conditions satisfied.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885590/000119312525200869/0001193125-25-200869-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885590/000119312525200869/d934691d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-200869

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer